Advances in Biomarkers Guide Breast Cancer Treatment
Recent advances in prognostic and predictive biomarkers, such as the Prosigna test, are improving treatment guidance for breast cancer, particularly for ER+/HER2- subtypes. These biomarkers help tailor chemotherapy decisions, enhancing personalized care and outcomes for patients with breast cancer.
Express Healthcare·




